SLNO
SOLENO THERAPEUTICS INCCompany with tickers: SLNO
CIK
1484565
Shares Outstanding
51,624,384
Price
Holdings
Short Volume
Short Interest
Fails to Deliver
SEC Filings
Earnings Calls
Insider Trading
Congress Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-03-27 | Manning Meredith | Chief Commercial Officer | Sell | 4,864 |
| 2026-03-27 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 4,256 |
| 2026-03-02 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Convert | 67,660 |
| 2026-03-02 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Award | 39,200 |
| 2026-03-02 | Fulk Jennifer | CHIEF FINANCIAL OFFICER | Other | 0 |
| 2026-01-21 | Manning Meredith | Chief Commercial Officer | Award | 28,600 |
| 2026-01-21 | Joshi Manher | Chief Development Officer | Award | 4,100 |
| 2026-01-21 | Hirano Patricia C | SEE REMARKS | Award | 10,400 |
| 2026-01-21 | Yen Kristen | SEE REMARKS | Award | 10,400 |
| 2026-01-21 | Yen Kristen | SEE REMARKS | Award | 11,900 |
| 2026-01-21 | Norrett Kevin | Chief Business Officer | Award | 3,500 |
| 2026-01-21 | Norrett Kevin | Chief Business Officer | Award | 4,000 |
| 2026-01-21 | Manning Meredith | Chief Commercial Officer | Award | 32,800 |
| 2026-01-21 | Mackaness James H | CHIEF FINANCIAL OFFICER | Award | 32,800 |
| 2026-01-21 | Mackaness James H | CHIEF FINANCIAL OFFICER | Award | 28,600 |
| 2026-01-21 | Joshi Manher | Chief Development Officer | Award | 4,700 |
| 2026-01-21 | Huang Michael F. | Sr. VP of Clinical Development | Award | 10,400 |
| 2026-01-21 | Huang Michael F. | Sr. VP of Clinical Development | Award | 11,900 |
| 2026-01-21 | Hirano Patricia C | SEE REMARKS | Award | 11,900 |
| 2026-01-21 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Award | 114,200 |
| 2026-01-21 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Award | 131,400 |
| 2025-12-15 | Manning Meredith | Chief Commercial Officer | Tax | 1,922 |
| 2025-12-15 | Mackaness James H | CHIEF FINANCIAL OFFICER | Tax | 2,013 |
| 2025-12-15 | Yen Kristen | SEE REMARKS | Tax | 904 |
| 2025-12-15 | Huang Michael F. | Sr. VP of Clinical Development | Tax | 812 |
| 2025-12-15 | Hirano Patricia C | SEE REMARKS | Tax | 904 |
| 2025-12-15 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Gift | 100,000 |
| 2025-12-15 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Tax | 7,620 |
| 2025-11-17 | Norrett Kevin | Chief Business Officer | Convert | 64,286 |
| 2025-11-17 | Norrett Kevin | Chief Business Officer | Award | 14,286 |
| 2025-11-17 | Norrett Kevin | Chief Business Officer | Other | 0 |
| 2025-11-10 | Joshi Manher | Chief Development Officer | Convert | 72,321 |
| 2025-11-10 | Joshi Manher | Chief Development Officer | Award | 16,071 |
| 2025-11-10 | Joshi Manher | Chief Development Officer | Other | 0 |
| 2025-10-13 | Hahn Mark W | Director | Award | 10,046 |
| 2025-10-13 | Hahn Mark W | Director | Other | 0 |
| 2025-07-01 | Hirano Patricia C | SEE REMARKS | Sell | 3,830 |
| 2025-06-24 | Hirano Patricia C | SEE REMARKS | Convert | 266 |
| 2025-06-24 | Hirano Patricia C | SEE REMARKS | Convert | 266 |
| 2025-06-24 | Hirano Patricia C | SEE REMARKS | Sell | 266 |
| 2025-06-05 | Volck Birgitte | Director | Award | 3,991 |
| 2025-06-05 | Sinclair Andrew | Director | Award | 3,991 |
| 2025-06-05 | Pauls Matthew | Director | Award | 3,991 |
| 2025-06-05 | Harris William G | Director | Award | 3,991 |
| 2025-06-05 | Bir Dawn Carter | Director | Award | 3,991 |
| 2025-04-01 | Hirano Patricia C | SEE REMARKS | Sell | 3,782 |
| 2025-03-28 | Vivo Opportunity, LLC | 10% Owner | Sell | 333,557 |
| 2025-03-28 | Pauls Matthew | Director | Convert | 5,937 |
| 2025-03-28 | Pauls Matthew | Director | Convert | 5,937 |
| 2025-03-28 | Pauls Matthew | Director | Sell | 5,937 |
| 2025-03-28 | Hirano Patricia C | SEE REMARKS | Sell | 3,394 |
| 2025-03-28 | Hirano Patricia C | SEE REMARKS | Convert | 2,691 |
| 2025-03-28 | Hirano Patricia C | SEE REMARKS | Convert | 2,691 |
| 2025-03-27 | Mackaness James H | CHIEF FINANCIAL OFFICER | Convert | 20,000 |
| 2025-03-27 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | 1,669 |
| 2025-03-27 | Mackaness James H | CHIEF FINANCIAL OFFICER | Convert | 20,000 |
| 2025-03-27 | Vivo Opportunity, LLC | 10% Owner | Sell | 1,100,000 |
| 2025-03-27 | Yen Kristen | SEE REMARKS | Convert | 4,888 |
| 2025-03-27 | Yen Kristen | SEE REMARKS | Sell | 1,769 |
| 2025-03-27 | Yen Kristen | SEE REMARKS | Convert | 4,888 |
| 2025-03-27 | Manning Meredith | Chief Commercial Officer | Convert | 37,000 |
| 2025-03-27 | Manning Meredith | Chief Commercial Officer | Convert | 37,000 |
| 2025-03-27 | Manning Meredith | Chief Commercial Officer | Sell | 668 |
| 2025-03-27 | Huang Michael F. | Sr. VP of Clinical Development | Sell | 371 |
| 2025-03-27 | Huang Michael F. | Sr. VP of Clinical Development | Convert | 10,000 |
| 2025-03-27 | Huang Michael F. | Sr. VP of Clinical Development | Convert | 10,000 |
| 2025-03-27 | Hirano Patricia C | SEE REMARKS | Convert | 6,000 |
| 2025-03-27 | Hirano Patricia C | SEE REMARKS | Sell | 1,418 |
| 2025-03-27 | Hirano Patricia C | SEE REMARKS | Convert | 6,000 |
| 2025-03-27 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Convert | 26,606 |
| 2025-03-27 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Convert | 26,606 |
| 2025-03-27 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sell | 14,183 |
| 2025-03-26 | Vivo Opportunity, LLC | 10% Owner | Sell | 400,000 |
| 2025-01-21 | Yen Kristen | SEE REMARKS | Award | 13,800 |
| 2025-01-21 | Yen Kristen | SEE REMARKS | Award | 6,400 |
| 2025-01-21 | Mackaness James H | CHIEF FINANCIAL OFFICER | Award | 14,500 |
| 2025-01-21 | Mackaness James H | CHIEF FINANCIAL OFFICER | Award | 31,000 |
| 2025-01-21 | Manning Meredith | Chief Commercial Officer | Award | 13,600 |
| 2025-01-21 | Manning Meredith | Chief Commercial Officer | Award | 29,200 |
| 2025-01-21 | Huang Michael F. | Sr. VP of Clinical Development | Award | 13,800 |
| 2025-01-21 | Huang Michael F. | Sr. VP of Clinical Development | Award | 6,400 |
| 2025-01-21 | Hirano Patricia C | SEE REMARKS | Award | 6,400 |
| 2025-01-21 | Hirano Patricia C | SEE REMARKS | Award | 13,800 |
| 2025-01-21 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Award | 53,900 |
| 2025-01-21 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Award | 115,600 |
| 2025-01-03 | Yen Kristen | SEE REMARKS | Sell | 2,340 |
| 2025-01-03 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | 3,791 |
| 2025-01-03 | Hirano Patricia C | SEE REMARKS | Sell | 1,459 |
| 2025-01-03 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sell | 10,154 |
| 2025-01-02 | Yen Kristen | SEE REMARKS | Sell | 2,322 |
| 2025-01-02 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | 3,762 |
| 2025-01-02 | Hirano Patricia C | SEE REMARKS | Sell | 1,447 |
| 2025-01-02 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sell | 10,077 |
| 2024-10-01 | Yen Kristen | SEE REMARKS | Sell | 2,789 |
| 2024-10-01 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | 7,248 |
| 2024-10-01 | Hirano Patricia C | SEE REMARKS | Sell | 2,789 |
| 2024-10-01 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sell | 19,413 |
| 2024-08-29 | Mackaness James H | CHIEF FINANCIAL OFFICER | Sell | 5,595 |
| 2024-08-29 | Hirano Patricia C | SEE REMARKS | Sell | 4,426 |
| 2024-08-29 | Anish Bhatnagar | Director, CHIEF EXECUTIVE OFFICER | Sell | 47,551 |